Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate Cancer

Marc B. Garnick; Ken Herrmann; Oliver Sartor; Daniel Spratt; Louise Emmett; Scott Tagawa; Daniela Oprea-Lager; Luke Nordquist; Shaemus Gleason; Roger Estafanos; Arthur J.A.T. Braat; Renu Eapen; Vinay Giri; Alberto Briganti

doi:10.1016/j.eururo.2026.03.002

Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate Cancer

Marc B. Garnick^*
, Ken Herrmann
, Oliver Sartor
, Daniel Spratt
, Louise Emmett
, Scott Tagawa
, Daniela Oprea-Lager
, Luke Nordquist
, Shaemus Gleason
, Roger Estafanos
, Arthur J.A.T. Braat
, Renu Eapen
, Vinay Giri
, Alberto Briganti
,

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Abstract

Take Home Message Local and androgen-deprivation therapies are guideline recommendations in localized and metastatic prostate cancer, respectively. However, in select patients the alternative use of radiopharmaceutical therapies may be considered to delay or avoid quality-of-life decline associated with other systemic treatments.

Original language	English
Pages (from-to)	1-6
Number of pages	6
Journal	European Urology
Volume	90
Issue number	1
Early online date	15 Apr 2026
DOIs	https://doi.org/10.1016/j.eururo.2026.03.002
Publication status	Published - Jul 2026

Access to Document

10.1016/j.eururo.2026.03.002

Cite this

@article{b352c6602e814b1ea20c6fe5368f8168,

title = "Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate Cancer",

abstract = "Take Home Message Local and androgen-deprivation therapies are guideline recommendations in localized and metastatic prostate cancer, respectively. However, in select patients the alternative use of radiopharmaceutical therapies may be considered to delay or avoid quality-of-life decline associated with other systemic treatments.",

author = "Garnick, \{Marc B.\} and Ken Herrmann and Oliver Sartor and Daniel Spratt and Louise Emmett and Scott Tagawa and Daniela Oprea-Lager and Luke Nordquist and Shaemus Gleason and Roger Estafanos and Braat, \{Arthur J.A.T.\} and Renu Eapen and Vinay Giri and Alberto Briganti",

note = "Publisher Copyright: {\textcopyright} 2026 European Association of Urology.",

year = "2026",

month = jul,

doi = "10.1016/j.eururo.2026.03.002",

language = "English",

volume = "90",

pages = "1--6",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate Cancer

AU - Garnick, Marc B.

AU - Herrmann, Ken

AU - Sartor, Oliver

AU - Spratt, Daniel

AU - Emmett, Louise

AU - Tagawa, Scott

AU - Oprea-Lager, Daniela

AU - Nordquist, Luke

AU - Gleason, Shaemus

AU - Estafanos, Roger

AU - Braat, Arthur J.A.T.

AU - Eapen, Renu

AU - Giri, Vinay

AU - Briganti, Alberto

PY - 2026/7

Y1 - 2026/7

N2 - Take Home Message Local and androgen-deprivation therapies are guideline recommendations in localized and metastatic prostate cancer, respectively. However, in select patients the alternative use of radiopharmaceutical therapies may be considered to delay or avoid quality-of-life decline associated with other systemic treatments.

AB - Take Home Message Local and androgen-deprivation therapies are guideline recommendations in localized and metastatic prostate cancer, respectively. However, in select patients the alternative use of radiopharmaceutical therapies may be considered to delay or avoid quality-of-life decline associated with other systemic treatments.

UR - https://www.scopus.com/pages/publications/105036683053

U2 - 10.1016/j.eururo.2026.03.002

DO - 10.1016/j.eururo.2026.03.002

M3 - Editorial

C2 - 41991401

AN - SCOPUS:105036683053

SN - 0302-2838

VL - 90

SP - 1

EP - 6

JO - European Urology

JF - European Urology

IS - 1

ER -

Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate Cancer

Abstract

Access to Document

Other files and links

Embargoed Document

Fingerprint

Cite this